An inverse relationship has been shown for adiponectin levels and breast, endometrial, prostate, colon, esophagus, pancreas, stomach, and myeloid leukemia; adiponectin was inversely associated with stage of disease in stomach, colorectal and prostate cancer [53,54,55,56,57,58]. This evidence concerns the gene ADIPOQ and prostate carcinoma.